NCT07788781

Brief Summary

This randomized controlled pilot trial evaluated the effectiveness of adding pain neuroscience education (PNE) to a therapeutic exercise program in adults with chronic musculoskeletal pain. Participants were randomly allocated in a 1:1 ratio to an experimental group receiving therapeutic exercise plus PNE or to a control group receiving therapeutic exercise alone. The intervention lasted 8 weeks. The primary objective was to evaluate the effect of the intervention on pain intensity. Secondary objectives included evaluating its effects on kinesiophobia, fear-avoidance beliefs, and muscle strength, as well as assessing the feasibility of the study protocol to inform the design of a future larger-scale randomized controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2026

Completed
Last Updated

August 26, 2026

Status Verified

August 1, 2026

Enrollment Period

2 months

First QC Date

August 19, 2026

Last Update Submit

August 24, 2026

Conditions

Keywords

Pain Neuroscience EducationTherapeutic Exercise KinesiophobiaFear-Avoidance BeliefsChronic Pain

Outcome Measures

Primary Outcomes (1)

  • Numeric Pain Rating Scale

    Pain Intensity. Pain intensity was assessed using the Numeric Pain Rating Scale (NPRS), based on the maximum pain experienced during the previous 7 days.

    Baseline and Week 9

Secondary Outcomes (7)

  • Kinesiophobia Assessed With the Tampa Scale for Kinesiophobia (TSK-11)

    Baseline and Week 9

  • Fear-Avoidance Beliefs Assessed With the Fear-Avoidance Beliefs Questionnaire (FABQ)

    Baseline and Week 9

  • Muscle Strength Assessed Using a Linear Velocity Transducer

    Baseline and Week 9

  • Recruitment Feasibility

    Through completion of the recruitment period

  • Adherence to the Intervention

    Up to 8 weeks

  • +2 more secondary outcomes

Study Arms (2)

Arm 1 Experimental

EXPERIMENTAL

Arm 1 Experimental: Therapeutic Exercise + Pain Neuroscience Education

Behavioral: Pain Neuroscience Education (PNE) + Therapeutic Exercise

Arm 2 - Control

ACTIVE COMPARATOR

Therapeutic Exercise Alone

Behavioral: Therapeutic Exercise

Interventions

Participants in the experimental group received four Pain Neuroscience Education (PNE) sessions over the 8-week intervention period, with one session every two weeks. The educational intervention aimed to facilitate the reconceptualization of pain through accessible explanations of the neurophysiological mechanisms involved in pain perception and modulation. Sessions were delivered online through educational videos and included examples and graphic materials. A brief questionnaire was administered after each session to verify attendance and understanding of the content.

Also known as: Arm 1
Arm 1 Experimental

Participants attended supervised 50-minute therapeutic exercise sessions, usually 1 to 3 times per week, during the 8-week intervention period. The structured program was primarily focused on strength training and also included an aerobic exercise component. Exercise frequency, intensity, duration, and progression were individualized according to each participant's characteristics and abilities.

Also known as: Arm 2
Arm 2 - Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years.
  • Chronic musculoskeletal pain lasting more than 3 months, regardless of pain location.
  • Provision of written informed consent to participate in the study.

You may not qualify if:

  • Psychiatric or psychological condition that could interfere with the performance or understanding of the therapeutic exercise program or the educational intervention.
  • Degenerative neurological disease or neurological disease affecting the central nervous system.
  • Recent surgery.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Studio Pilates Fisioterapia

Pontevedra, Pontevedra, 36005, Spain

Location

MeSH Terms

Conditions

Chronic Pain

Interventions

Exercise TherapyDMAC2L protein, human

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in a 1:1 ratio to either the experimental group (therapeutic exercise plus pain neuroscience education) or the control group (therapeutic exercise alone)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 19, 2026

First Posted

August 26, 2026

Study Start

May 1, 2026

Primary Completion

July 3, 2026

Study Completion

July 3, 2026

Last Updated

August 26, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) are not planned to be publicly shared. Participant confidentiality and protection of personal data will be maintained in accordance with applicable data protection regulations and the ethical requirements of the study.

Locations